Dihydrotestosterone (DHT) (referred to as androstanolone or stanolone when used medically) can also be used in place of testosterone as an androgen. The availability of DHT is limited; it is not available in the United States or Canada, for instance, but it is available in certain European countries, including the United Kingdom , France , Spain , Belgium , Italy , and Luxembourg .  DHT is available in formulations including topical gel, buccal or sublingual tablets, and as esters in oil for intramuscular injection.  Relative to testosterone, and similarly to many synthetic AAS, DHT has the potential advantages of not being locally potentiated in so-called androgenic tissues that express 5α-reductase (as DHT is already 5α-reduced) and of not being aromatized into an estrogen (it is not a substrate for aromatase).
BIOIDENTICAL HORMONE REPLACEMENT Millions of women today experience some kind of health issue relating to their hormones, ranging from premenstrual moodiness or sugar cravings, to severe hot flashes and sleep problems during menopause. Infertility and miscarriages are becoming more and more common. And while more and more women are searching for solutions, frequently the only solution offered to them by their doctors is to put artificial hormones into their body to relieve their symptoms. Hence the millions of prescriptions for […]